Ambucetamide: Difference between revisions

Revision as of 15:30, 28 March 2023 editHeadbomb (talk \| contribs)Edit filter managers, Autopatrolled, Extended confirmed users, Page movers, File movers, New page reviewers, Pending changes reviewers, Rollbackers, Template editors454,470 edits ce← Previous edit		Latest revision as of 19:59, 23 September 2024 edit undoJWBE (talk \| contribs)Extended confirmed users10,127 edits removed Category:Phenol ethers; added Category:4-Methoxyphenyl compounds using HotCat
Line 59:		Line 59:
	]		]
	]		]
	]		]
	]		]
	]		]

Latest revision as of 19:59, 23 September 2024

Chemical compound Pharmaceutical compound

Ambucetamide
Clinical data

ATC code	none
Identifiers
IUPAC name 2-(dibutylamino)-2-(4-methoxyphenyl)acetamide
CAS Number	519-88-0
PubChem CID	10616
ChemSpider	10171
UNII	131B408RZI
ChEMBL	ChEMBL2104638
CompTox Dashboard (EPA)	DTXSID4057760
ECHA InfoCard	100.007.527
Chemical and physical data
Formula	C₁₇H₂₈N₂O₂
Molar mass	292.423 g·mol
3D model (JSmol)	Interactive image
SMILES O=C(N)C(c1ccc(OC)cc1)N(CCCC)CCCC
InChI InChI=1S/C17H28N2O2/c1-4-6-12-19(13-7-5-2)16(17(18)20)14-8-10-15(21-3)11-9-14/h8-11,16H,4-7,12-13H2,1-3H3,(H2,18,20) Key:WUSAVCGXMSWMQM-UHFFFAOYSA-N
(what is this?) (verify)

Ambucetamide is an antispasmodic found to be particularly effective for the relief of menstrual pain. It was discovered in 1953 by Paul Janssen.

Hoekstra JB, Fisher DS, Cull KM, Tisch DE, Dickison HL (September 1957). "Studies with a uterine antispasmodic, ambucetamide". Journal of the American Pharmaceutical Association. 46 (9): 564–568. doi:10.1002/jps.3030460915. PMID 13491452.
Pickles VR, Clitheroe HJ (March 1960). "The effects of ambucetamide on human myometrial and other preparations, and its antagonism to the menstrual stimulant". British Journal of Pharmacology and Chemotherapy. 15 (1): 128–30. doi:10.1111/j.1476-5381.1960.tb01220.x. PMC 1481989. PMID 14432761.

This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it.